Search Results - "Fallick M"

POSA202 Occurrence of Cardiovascular-Related Hospitalization and Emergency Department (ED) Visits for Men with Prostate Cancer Initiating Systemic Androgen Deprivation Therapy (ADT) in the United States.

Authors: Fallick, M Dufour, R Jiang, T et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS126-S126. 1p.

Pratiques et veinites.

Authors: Troupel, S. Fallick, M. Bessou, K. et al.

Source: Medecine & Maladies Infectieuses. Jun2017 Supplement, Vol. 47, pS156-S156. 1p.

Patient-Reported Xerostomia in Men Treated with Prostate Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy.

Authors: Kallam, D. Gaudian, K. Gudenkauf, L. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pe372-e373. 2p.

PCR172 Development of a Novel Patient-Reported Outcome (PRO) Measure to Assess Hormonal-Based Treatment Symptoms and Their Impacts in Patients with Prostate Cancer.

Authors: Chladek, M Hunsche, E Hudgens, S et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS573-S574. 2p.

RWD161 Real World Utilization of Androgen Deprivation Therapy Among Urology Practices: Characterizing Initiation and Transition to Relugolix for Patients with Prostate Cancer (THE REAL ADT TRANSITIONS STUDY).

Authors: Gandhi, R. Yang, E. Sangha, P. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS392-S392. 1p.

Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer.

Authors: Friedrich NA Janes JL Parrish J et al.

Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2026 Mar; Vol. 29 (1), pp. 103-110. Date of Electronic Publication: 2025 Jul 04.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer.

Authors: Gaudian K Koh MJ Collins RR et al.

Source: Frontiers in oncology [Front Oncol] 2025 Jan 30; Vol. 15, pp. 1540482. Date of Electronic Publication: 2025 Jan 30 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer.

Authors: Ross A Brewer K Hudgens S et al.

Source: Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3076-3088. Date of Electronic Publication: 2024 Jun 11.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.

Authors: Shore ND Mehlhaff BA Cookson MS et al.

Source: Advances in therapy [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 4919-4927. Date of Electronic Publication: 2023 Sep 15.

Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther

Chronic Prostate Cancer-Related Symptoms and Toxicities Following Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy.

Authors: Kallam D Gaudian K Collins R et al.

Source: Cureus [Cureus] 2025 May 29; Vol. 17 (5), pp. e85034. Date of Electronic Publication: 2025 May 29 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.

Authors: Gallagher L Xiao J Hsueh J et al.

Source: Frontiers in oncology [Front Oncol] 2023 Oct 17; Vol. 13, pp. 1289249. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer.

Authors: Friedrich N Janes J Parrish J et al.

Source: Research square [Res Sq] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE

Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.

Authors: Tutrone R Saad F George DJ et al.

Source: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 906-913. Date of Electronic Publication: 2023 Dec 23.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.

Authors: Spratt DE George DJ Shore ND et al.

Source: JAMA oncology [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.

Authors: Spratt DE Dorff T McKay RR et al.

Source: Future oncology (London, England) [Future Oncol] 2024 Apr; Vol. 20 (12), pp. 727-738. Date of Electronic Publication: 2024 Mar 15.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Incidence of Cardiovascular Events in Patients With Prostate Cancer and Treated With Androgen Deprivation Therapy.

Authors: Lowentritt B Fallick M Pruett J et al.

Source: Urology practice [Urol Pract] 2024 Jan; Vol. 11 (1), pp. 154-161. Date of Electronic Publication: 2023 Nov 01.

Publication Type: Observational Study; Journal Article

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101635343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-0787 (Electronic) Linking ISSN: 23520779 NLM ISO Abbreviation: Urol Pract Subsets: MEDLINE

Exploring Higher-Order Conceptual Learning in an Arthropod with a Large Multisensory Processing Center.

Authors: Lehmann KDS Shogren FG Fallick M et al.

Source: Insects [Insects] 2022 Jan 12; Vol. 13 (1). Date of Electronic Publication: 2022 Jan 12.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101574235 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4450 (Print) Linking ISSN: 20754450 NLM ISO Abbreviation: Insects Subsets: PubMed not MEDLINE

Leydig cell tumors presenting as azoospermia.

Authors: Fallick ML Lin WW Lipshultz LI

Source: The Journal of urology [J Urol] 1999 May; Vol. 161 (5), pp. 1571-2.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print Cited Medium: Print ISSN: 0022-5347 (Print) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

Varicocelectomy improves sperm strict morphology and motility.

Authors: Schatte EC Hirshberg SJ Fallick ML et al.

Source: The Journal of urology [J Urol] 1998 Oct; Vol. 160 (4), pp. 1338-40.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print Cited Medium: Print ISSN: 0022-5347 (Print) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma.

Authors: Long JP Fallick ML LaRock DR et al.

Source: The Journal of urology [J Urol] 1998 Feb; Vol. 159 (2), pp. 477-84.

Publication Type: Clinical Trial; Journal Article

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print Cited Medium: Print ISSN: 0022-5347 (Print) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE